Arete Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
11,979
+684
| +6% | +$75.8K | 0.09% | 213 |
|
|
2025
Q1 | $1.27M | Buy |
11,295
+386
| +4% | +$43.2K | 0.1% | 217 |
|
|
2024
Q4 | $1.01M | Buy |
10,909
+1,125
| +11% | +$104K | 0.07% | 254 |
|
|
2024
Q3 | $817K | Sell |
9,784
-802
| -8% | -$67K | 0.07% | 262 |
|
|
2024
Q2 | $723K | Sell |
10,586
-453
| -4% | -$30.9K | 0.06% | 304 |
|
|
2024
Q1 | $809K | Sell |
11,039
-3,224
| -23% | -$236K | 0.07% | 238 |
|
|
2023
Q4 | $1.16M | Buy |
14,263
+988
| +7% | +$80K | 0.09% | 223 |
|
|
2023
Q3 | $995K | Sell |
13,275
-2,351
| -15% | -$176K | 0.17% | 128 |
|
|
2023
Q2 | $824K | Buy |
15,626
+5,504
| +54% | +$290K | 0.07% | 246 |
|
|
2023
Q1 | $840K | Sell |
10,122
-5,270
| -34% | -$437K | 0.07% | 244 |
|
|
2022
Q4 | $1.32B | Buy |
15,392
+3,761
| +32% | +$323M | 0.12% | 157 |
|
|
2022
Q3 | $717K | Buy |
11,631
+6,860
| +144% | +$423K | 0.07% | 232 |
|
|
2022
Q2 | $295K | Buy |
4,771
+867
| +22% | +$53.6K | 0.03% | 336 |
|
|
2022
Q1 | $232K | Buy |
3,904
+604
| +18% | +$35.9K | 0.02% | 444 |
|
|
2021
Q4 | $239K | Buy |
3,300
+22
| +0.7% | +$1.59K | 0.02% | 430 |
|
|
2021
Q3 | $229K | Buy |
+3,278
| New | +$229K | 0.03% | 377 |
|
|
2020
Q3 | – | Sell |
-3,141
| Closed | -$242K | – | 394 |
|
|
2020
Q2 | $242K | Buy |
+3,141
| New | +$242K | 0.04% | 325 |
|
|
2018
Q2 | – | Sell |
-12,836
| Closed | -$968K | – | 373 |
|
|
2018
Q1 | $968K | Sell |
12,836
-852
| -6% | -$64.3K | 0.32% | 80 |
|
|
2017
Q4 | $981K | Sell |
13,688
-961
| -7% | -$68.9K | 0.32% | 76 |
|
|
2017
Q3 | $1.19M | Buy |
14,649
+5,233
| +56% | +$424K | 0.47% | 59 |
|
|
2017
Q2 | $666K | Buy |
9,416
+1,093
| +13% | +$77.3K | 0.3% | 92 |
|
|
2017
Q1 | $565K | Sell |
8,323
-215
| -3% | -$14.6K | 0.25% | 90 |
|
|
2016
Q4 | $611K | Buy |
+8,538
| New | +$611K | 0.28% | 77 |
|